Article
Inflammatory biomarkers for asthma endotyping and consequent personalized therapy.
Expert review of clinical immunology - 1 Jul 2017
Ciprandi Giorgio, Tosca Maria Angela, Silvestri Michela, Ricciardolo Fabio Luigi Massimo
Abstract excerpt
INTRODUCTION: We argue that asthma be considered a syndrome caused by multiple inflammatory pathogenic processes. Bronchial hyperresponsiveness, reversible airflow limitation, and chronic airway inflammation characterize asthma pathophysiology. Personalized Medicine, i.e. a tailored management approach, is appropriate for asthma management and is based on the identification of discrete phenotypes and endotypes....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
